Development of a Family Intervention to Address Drug Use and HIV in Vietnam
NCT ID: NCT01540188
Last Updated: 2016-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
230 participants
INTERVENTIONAL
2010-07-31
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Two teams with complementary expertise collaborate to implement this study: the UCLA team and the Vietnamese team from the Vietnam National Institute of Hygiene \& Epidemiology (NIHE). The study has two phases:
* In Phase 1, the investigators develop the content, format and an implementation plan for the intervention from a focus group of 10 service providers, administrators and community leaders, and through in-depth interviews with 40 IDUs (20 HIV+ and 20 HIV-) recruited from the local drug rehabilitation center (the "06 Center") and from two local communities (Duu Lau and Gia Cam), as well as in-depth interviews with 20 of the IDUs family members (FM). Based on the findings, the investigators collaborate on designing a Vietnamese-specific family intervention for IDUs and their family members.
* In Phase 2, the investigators pilot the intervention in the local commune health centers in Viet Tri, Phu Tho. Eighty IDUs (HIV+/HIV-) and 80 of their family members are recruited from 4 communes and the 06 Center in Viet Tri city, and randomized into a intervention group and a control group. After the 4-week intervention, 3-month and 6-month follow-ups are conducted to assess the effectiveness of the intervention. Participants randomized to the control group only complete the assessments (baseline, 3-, and 6-month) at the same time points.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhancing the Role of Commune Health Workers in HIV and Drug Control: A Randomized Controlled Trial
NCT02130921
Formative Phase of Reducing Hazardous Alcohol Use & HIV Viral Load
NCT02153216
Implementing Tobacco Use Treatment in HIV Clinics Vietnam
NCT05162911
A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts
NCT00038688
Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU
NCT01689545
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific aims of the study are:
1. To document the challenges of drug use and HIV for IDUs and their family members;
2. To examine the acceptability and feasibility of a family-based intervention for IDU and their family members;
3. To examine whether the IDUs and family members in the intervention group, compared to those in the standard care group, will have significantly improved health, mental health, and quality of life outcomes, including health seeking, reduced sexual and drug use risk behaviors, increased HIV testing, and reduced caregiver burden; and
4. To examine how outcomes of the IDUs and family members are mediated by family indicators such as family cohesion, stress and symptom management, stigma and harm reduction, HIV disclosure, and treatment adherence.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Starndard care arm
Participants of the standard care arm are control groups of IDUs and family members. They do not attend intervention sessions.
No interventions assigned to this group
Intervention arm
Intervention for IDUs: there are 4 sessions of the intervention with the following titles: My family, my health, my actions, my community.
Intervention for family members: there are 4 intervention sessions for family members covering the following topics: my family, my responsibility, my support and my community
Family Intervention to Address Drug Use and HIV in Vietnam
Intervention for IDUs: there are 4 sessions of the intervention with the following titles: My family, my health, my actions, my community.
Intervention for family members: there are 4 intervention sessions for family members covering the following topics: my family, my responsibility, my support and my community
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Family Intervention to Address Drug Use and HIV in Vietnam
Intervention for IDUs: there are 4 sessions of the intervention with the following titles: My family, my health, my actions, my community.
Intervention for family members: there are 4 intervention sessions for family members covering the following topics: my family, my responsibility, my support and my community
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 or over
* Either HIV + or HIV- in blood test
* A current or past injection drug user
* Disclosure of drug use status and HIV positive status (if positive) to their family members
* Voluntary informed consent
Family members:
* Age 18 or over
* Immediate or extended family member of an IDU and living with the IDU.
* Previous knowledge of the drug use and HIV status (if positive) of the IDU.
* Voluntary informed consent
Exclusion Criteria
* Inability to give informed consent
* Has not disclosed the drug use status and HIV status (if positive) to family member
* Not a current or past injection drug user
Family members:
* Inability to give informed consent
* Does not know the drug use status and HIV status (if positive) of the IDU in their family
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Hygiene and Epidemiology, Vietnam
OTHER
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Li Li
Principal investigator, Professor-in-Residence
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Li, Ph.D
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Commune health centers
Việt Trì, Phu Tho, Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.